Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8103 items from SEC EDGAR · filings · clear filters
- 8-K - Flash Sports & Media Holdings, Inc. (0001706524) (Filer)
Flash Sports & Media Holdings filed a Form 8-K on September 29, 2026, reporting a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - ALASKA AIR GROUP, INC. (0000766421) (Filer)
Alaska Air Group, Inc. filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - FORD MOTOR CREDIT CO LLC (0000038009) (Filer)
Ford Motor Credit Co. LLC filed a Form 8-K on September 29, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Keros Therapeutics, Inc. (0001664710) (Filer)
Keros Therapeutics, Inc. filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.
- 8-K - FIRST UNITED CORP/MD/ (0000763907) (Filer)
First United Corp filed a Form 8-K on September 29, 2026 reporting the departure, election, or appointment of directors and certain officers, and disclosing compensatory arrangements for those officers.
- 8-K - TOP Financial Group Ltd (0001848275) (Filer)
TOP Financial Group Ltd filed a Form 8-K on September 29, 2026, reporting director/officer departures, elections, appointments and related compensation arrangements, and including its financial statements and exhibits.
- 8-K - Imunon, Inc. (0000749647) (Filer)
Imunon, Inc. filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, amendments to its articles of incorporation and bylaws including a fiscal year change, and accompanying financial statements and exhibits.
- 8-K - SurgePays, Inc. (0001392694) (Filer)
SurgePays, Inc. filed an 8-K on September 29, 2026 reporting a notice of delisting or failure to satisfy a continued listing rule and indicating a planned transfer of its listing.
- 8-K - Allarity Therapeutics, Inc. (0001860657) (Filer)
Allarity Therapeutics filed a Form 8-K on September 29, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Bloomin' Brands, Inc. (0001546417) (Filer)
Bloomin' Brands filed an 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - ATOSSA THERAPEUTICS, INC. (0001488039) (Filer)
Atossa Therapeutics, Inc. filed a Form 8-K on September 29, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - TransDigm Group INC (0001260221) (Filer)
TransDigm Group filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and the inclusion of financial statements and related exhibits.
- 8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)
Unicycive Therapeutics filed a Form 8-K reporting director/officer departures and appointments, related compensatory arrangements, other events, and accompanying financial statements and exhibits.
- 8-K - SOUNDTHINKING, INC. (0001351636) (Filer)
SoundThinking, Inc. filed a Form 8-K reporting a material definitive agreement, the departure and appointment of directors and officers with related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer)
Cartesian Therapeutics filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Invivyd, Inc. (0001832038) (Filer)
Invivyd, Inc. filed a Form 8-K on September 29, 2026 (Accession No. 0001193125-26-406007), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)
Aquestive Therapeutics filed a Form 8-K on September 29, 2026, reporting director/officer changes and related compensation arrangements, and including its financial statements and related exhibits.
- 8-K - JELD-WEN Holding, Inc. (0001674335) (Filer)
JELD-WEN Holding, Inc. filed a Form 8-K on September 29, 2026, disclosing a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
Iovance Biotherapeutics, Inc. filed a Form 8-K on September 29, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - SHERWIN WILLIAMS CO (0000089800) (Filer)
Sherwin-Williams filed an 8-K reporting entry into and termination of material definitive agreements, creation of a direct financial obligation, other events, and accompanying financial statements and exhibits.
- 8-K - 1 800 FLOWERS COM INC (0001084869) (Filer)
1-800 Flowers filed a Form 8-K on September 29, 2026, reporting entry into a material definitive agreement, providing a Regulation FD disclosure, and including financial statements and related exhibits.
- 8-K - Altimmune, Inc. (0001326190) (Filer)
Altimmune, Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors or officers, and disclosed compensatory arrangements for those officers.
- 8-K - BeyondSpring Inc. (0001677940) (Filer)
BeyondSpring Inc. filed a Form 8-K on September 29, 2026, reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.
- 8-K - Aldeyra Therapeutics, Inc. (0001341235) (Filer)
Aldeyra Therapeutics, Inc. filed an 8-K with the SEC on September 29, 2026 (Accession No. 0001193125-26-405954), including a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - CID Holdco, Inc. (0002033770) (Filer)
CID Holdco, Inc. filed a Form 8-K on September 29, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - CARMAX INC (0001170010) (Filer)
CarMax Inc. filed an 8-K on September 29, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Immix Biopharma, Inc. (0001873835) (Filer)
Immix Biopharma, Inc. filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Atlantic Union Bankshares Corp (0000883948) (Filer)
Atlantic Union Bankshares Corp filed a Form 8-K on September 29, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - T1 Energy Inc. (0001992243) (Filer)
T1 Energy Inc. filed an 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation or off-balance-sheet arrangement, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - Alzamend Neuro, Inc. (0001677077) (Filer)
Alzamend Neuro, Inc. filed a Form 8-K with the SEC on September 29, 2026, including a Regulation FD disclosure and financial statements with related exhibits.